Particularly, we demonstrated that BRD9 mediates the enrichment of H3K27ac at ENO2 and ALDOC gene loci, thereby enhancing the glycolytic activities of colon cancer cells. The gene discussed is ALDOC; the disease is malignant colon neoplasm.